Cardinal Health Inc CAH.N reported quarterly adjusted earnings of $2.35 per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of $2.08. The mean expectation of fifteen analysts for the quarter was for earnings of $2.17 per share. Wall Street expected results to range from $2.04 to $2.22 per share.
Revenue fell 0.1% to $54.88 billion from a year ago; analysts expected $55.35 billion.
Cardinal Health Inc's reported EPS for the quarter was $2.10.
The company reported quarterly net income of $506 million.
Cardinal Health Inc shares had risen by 2.6% this quarter and gained 19.5% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 0.6% in the last three months.
In the last 30 days, two analysts negatively revised earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy," 5 "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy"
Wall Street's median 12-month price target for Cardinal Health Inc is $150.00
This summary was machine generated from LSEG data May 1 at 01:32 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Mar. 31 2025 | 2.17 | 2.35 | Beat |
Dec. 31 2024 | 1.76 | 1.93 | Beat |
Sep. 30 2024 | 1.62 | 1.88 | Beat |
Jun. 30 2024 | 1.74 | 1.84 | Beat |